Skip to main content
drug protocol number
191 57
drug sponsor
Bayer
drug study
Aflibercept
drug trial site
King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Khalid University Hospital (Riyadh)
drug status
Ongoing
drug phase